603 results on '"Wang, David Q-H."'
Search Results
2. Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation
3. Impact of Endocrine Disorders on Gastrointestinal Diseases
4. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
5. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3
6. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease
7. Overcoming Ductal Block: Emergency ERCP and Sphincterotomy Plus Common Bile Duct Stenting Improves Therapeutic Outcomes in Severe Gallstone Pancreatitis
8. A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice
9. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism
10. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
11. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)
12. Impact of Endocrine Disorders on Gastrointestinal Diseases
13. Mitochondria in Liver Diseases
14. Similarities and differences between biliary sludge and microlithiasis: Their clinical and pathophysiological significances
15. Cholecystectomy and risk of metabolic syndrome
16. Silencing steroid receptor coactivator-1 in the nucleus of the solitary tract reduces estrogenic effects on feeding and apolipoprotein A-IV expression
17. Critical Care Aspects of Gallstone Disease
18. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
19. Bile Acid Physiology
20. Bile Acids and Cancer: Direct and Environmental-Dependent Effects
21. New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile
22. Hepatocytes and Bile Formation
23. Bile Formation and Pathophysiology of Gallstones
24. Impact of Endocrine Disorders on Gastrointestinal Diseases
25. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats
26. The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice
27. Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice
28. Obesity and the risk and prognosis of gallstone disease and pancreatitis
29. Pathophysiology of Cholesterol Gallstone Disease
30. Medical Treatment of Gallstone Disease
31. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling
32. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats
33. An update on the pathogenesis of cholesterol gallstone disease
34. Mouse models of gallstone disease
35. Transintestinal cholesterol excretion: A secondary, nonbiliary pathway contributing to reverse cholesterol transport
36. The dangerous link between childhood and adulthood predictors of obesity and metabolic syndrome
37. Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation
38. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract
39. Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus
40. Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis
41. Gallstones
42. Gallstones
43. Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism
44. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice
45. Gallstones
46. Impact of Sequential Lipid Meals on Lymphatic Lipid Absorption and Transport in Rats
47. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
48. The pros and cons of biological effects of herbs and herb-derived compounds on liver tumorigenesis
49. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice
50. Biliary lipids and cholesterol gallstone disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.